Literature DB >> 7916157

Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.

P Bollini1, S Pampallona, M J Orza, M E Adams, T C Chalmers.   

Abstract

Effectiveness and side-effects of high- versus low-dose neuroleptic treatment of chronic psychosis have been assessed through a meta-analysis of 22 published randomized control trials comparing different neuroleptic doses. No incremental clinical improvement was found at doses above 375 mg equivalent of chlorpromazine, while a significant increase in adverse reactions was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916157     DOI: 10.1017/s003329170002729x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  17 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.

Authors:  J Geddes; N Freemantle; P Harrison; P Bebbington
Journal:  BMJ       Date:  2000-12-02

Review 3.  Understanding antipsychotic "atypicality": a clinical and pharmacological moving target.

Authors:  Gary Remington
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

4.  Psychotropic drug prescription in rehabilitation. A survey in Hong Kong.

Authors:  G S Ungvari; A H Pang; H F Chiu; C K Wong; F C Lum
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-09       Impact factor: 4.328

Review 5.  Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors:  Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

Review 6.  Antipsychotic dosing: found in translation.

Authors:  Gary Remington; Gagan Fervaha; George Foussias; Ofer Agid; Peter Turrone
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

Review 7.  Conventional versus novel antipsychotics: changing concepts and clinical implications.

Authors:  G Remington; S A Chong
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

8.  Predominant effects of midazolam for conscious sedation: benefits beyond the early postoperative period.

Authors:  Kotoe Kamata; Satoshi Hagihira; Ryu Komatsu; Makoto Ozaki
Journal:  J Anesth       Date:  2010-09-17       Impact factor: 2.078

9.  Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey.

Authors:  Lorenza Magliano; Andrea Fiorillo; Manuela Guarneri; Cecilia Marasco; Corrado De Rosa; Claudio Malangone; Mario Maj
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

Review 10.  Aripiprazole: dose-response relationship in schizophrenia and schizoaffective disorder.

Authors:  Shubhra Mace; David Taylor
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.